Protesters Target GSK Over HIV Drug Patent

Law360, New York (August 7, 2006, 12:00 AM EDT) -- Protests have erupted in Thailand as its government prepares to grant a patent to British drug maker GlaxoSmithKline for a popular HIV treatment, despite the fact that an appeal over patentability hasn’t yet been ruled on.

Hundreds of Thai demonstrators, many of them living with HIV/AIDS, staged a noisy protest at GSK’s headquarters in Bangkok, arguing that an increase in the cost of the anti-retroviral will threaten lives.

In the world of generic drugs, such arguments are hardly new. But the activists’ complaints have transcended moral...
To view the full article, register now.